2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …
the greatest medical challenge in decades. We provide a comprehensive review of the …
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary …
M Ambrosetti, A Abreu, U Corrà… - European journal of …, 2021 - academic.oup.com
Secondary prevention through comprehensive cardiac rehabilitation has been recognized
as the most cost-effective intervention to ensure favourable outcomes across a wide …
as the most cost-effective intervention to ensure favourable outcomes across a wide …
The promise of digital healthcare technologies
Digital health technologies have been in use for many years in a wide spectrum of
healthcare scenarios. This narrative review outlines the current use and the future strategies …
healthcare scenarios. This narrative review outlines the current use and the future strategies …
[HTML][HTML] Applying artificial intelligence to wearable sensor data to diagnose and predict cardiovascular disease: a review
Cardiovascular disease (CVD) is the world's leading cause of mortality. There is significant
interest in using Artificial Intelligence (AI) to analyse data from novel sensors such as …
interest in using Artificial Intelligence (AI) to analyse data from novel sensors such as …
Lifestyle factors, self-management and patient empowerment in diabetes care
E Lambrinou, TB Hansen… - European journal of …, 2019 - journals.sagepub.com
Although management of diabetes mellitus is improving, inadequately managed cases still
exist. Prevention of diabetes mellitus requires an integrated and holistic approach based on …
exist. Prevention of diabetes mellitus requires an integrated and holistic approach based on …
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of the European …
The role of comprehensive cardiac rehabilitation is well established in the secondary
prevention of cardiovascular diseases such as coronary artery disease and heart failure …
prevention of cardiovascular diseases such as coronary artery disease and heart failure …
Recent successes in heart failure treatment
Remarkable recent advances have revolutionized the field of heart failure. Survival has
improved among individuals with heart failure and a reduced ejection fraction and for the …
improved among individuals with heart failure and a reduced ejection fraction and for the …
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from …
A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …